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Abstract Image-guided diagnostic and therapeutic proce-
dures are related to, or performed under, some kind of
imaging. Such imaging may be direct inspection (as in open
surgery) or indirect inspection as in endoscopy or laparos-
copy. Common to all these techniques is the transformation
of optical and visible information to a monitor or the eye of
the operator. Image-guided therapy (IGT) differs by using
processed imaging data acquired before, during and after a
wide range of different imaging techniques. This means that
the planning, performing and monitoring, as well as the
control of the therapeutic procedure, are based and depen-
dent on the “virtual reality” provided by imaging
investigations. Since most of such imaging involves radiol-
ogy in the broadest sense, there is a need to characterise IGT
in more detail. In this paper, the technical, medico-legal and
medico-political issues will be discussed. The focus will be
put on state-of-the-art imaging, technical developments,
methodological and legal requisites concerning radiation
protection and licensing, speciality-specific limitations and
crossing specialty borders, definition of technical and qual-
ity standards, and finally to the issue of awareness of IGT
within the medical and public community. The specialty-
specific knowledge should confer radiologists with a signif-
icant role in the overall responsibility for the imaging-
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related processes in various non-radiological specialties.
These processes may encompass purchase, servicing, qual-
ity management, radiation protection and documentation,
also taking responsibility for the definition and compliance
with the legal requirements regarding all radiological imag-
ing performed by non-radiologists.
Keywords Image guided therapy . Health care . Patient
service . Quality standards
Introduction
During the last 30 years, image-guided therapies—with
guidance ranging from ultrasound (US) to magnetic reso-
nance imaging (MRI)—have been used increasingly to treat
patients suffering from oncological and vascular diseases.
Parallel to the development of endovascular and intratu-
moral techniques, advancements in imaging have contribut-
ed greatly to improve the clinical results of percutaneous
minimally invasive treatments in nearly all medical fields
and specialties.
Image-guided therapy (IGT) can be defined as any type
of local therapy based on identifying a target, targeting the
target, monitoring the procedure, and often monitoring the
local effect (immediate follow-up) by any kind of radiological
imaging at various contrast resolutions, as well as spatial and
temporal resolutions for active localisation and supervision.
These procedures are performed in environments providing
the necessary imaging techniques, such as radiology, nuclear
medicine, radiotherapy and surgical suites.
Compared with conventional surgical approaches, IGT
uses technically generated and processed imaging data from
any imaging equipment acquired before, during and after a
specific procedure. This means that planning, performing
and monitoring, as well as controlling a procedure is
based and dependent on the “virtual” reality provided
by imaging.
In this white paper, IGT will be reviewed with regard to:
& Defining state-of-the-art techniques focused on diagnosis
and therapy, including present and future developments.
& Technical, methodological and legal (radiation protection,
“licensing” according to the assignment to medical spe-
cialties) characteristics of imaging guidance and therapy.
& Medical specialty-specific limitations and “borders” for
present and future techniques (e.g. hybrid operating rooms).
& A framework for increasing the profile and recognition
of IGT in terms of training and education, research and
public awareness.
& The role of radiologists in defining quality standards and
professional relationships within IGT initiatives outside
radiology departments.
Role of IGT at present and future developments
The role of image guidance for percutaneous and intravas-
cular treatments is to ensure a precise, effective and safe
therapy (e.g. complete tumour destruction without injury to
critical structures). Therefore, image guidance during inter-
ventional therapies may provide an exact planning and
targeting, rapid imaging for positioning of the instrument,
reliable monitoring during the course of treatment, and
control during the same session [1]. Planning before or
during the treatment means exact localisation of the targeted
tissue and surrounding organs; targeting corresponds to the
placement of a catheter or probe into the targeted area;
monitoring describes the observation of changes during
therapy; control is related to imaging of the response to
treatment and efficacy, and early diagnosis of adverse
effects during the session.
Therefore, ideal qualities of imaging for guidance of
interventional therapies include:
& Adequate target/tissue contrast with clear demarcation
between targeted structure and the surrounding anatomy.
& Ultrafast real-time or near real-time imaging.
& Multiplanar and interactive imaging capabilities.
& Visualisation of therapy effects, including safetymargin, for
ablation therapy during and at the end of the procedure, as
far as possible including three-dimensional (3D) evaluation.
Imaging requirements are often different depending
on the kind of intervention, principally between percu-
taneous, vascular and open interventions. Nowadays, no
single imaging investigation can encompass the entire
clinical requirements for minimally invasive therapy. For
example, MRI—due to superior sensitivity and specific-
ity even in small lesions—might provide image guid-
ance in percutaneous ablative therapy, but fast, near
real-time imaging, possible with US and MRI, can also
easily facilitate percutaneous access. However, it is also
possible to have fast and accurate guidance by CT,
applying CT fluoroscopy imaging, with the drawback
of causing radiation exposure for both the intervention-
alist and for the patient.
For intravascular therapies, an exact knowledge of the vas-
cular anatomy (for access routes) and associated abnormalities
(stenosis, occlusion, tumour feeding vessels) is essential for
planning the treatment and for proper catheter positioning that
usually may be done by 2D digital subtraction angiography.
Recent advances in imaging technology produce CT-like soft-
tissue images, allowing identification of complex vascular sit-
uations, which are provided in well-equipped environments.
Nevertheless, it is debatable whether such techniques have to
be implemented in all hybrid operating theatres with respect to
the limited access, limited need and the related high costs. In
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this context, treatment and cost effectiveness should overcome
particular professional interests of specific specialties.
Intraoperative open surgery also clearly benefits from IGT,
as the precise location and definition of the characteristics of
the lesion cannot be possible without the use of virtual visual-
isation and parametric demonstration of tissue changes. As an
example, CT and MRI guidance are increasingly used
during brain surgery in order to locate the pathological
abnormality. IGT has revolutionised traditional surgical
techniques by providing surgeons with a way to navi-
gate through the body using several 3D images and
tools. A future approach to further improve the preci-
sion of targeting and guiding in IGTmay be an integration of
robotic assistance into interventional suites. Compatible ro-
botic assistance should operate without interfering with instru-
ment placement, during control after positioning and at
controlling after treatment.
Nevertheless, the role of image guidance for a growing
wide variety of medical specialities (e.g. surgery, orthopaedic
surgery, neurosurgery, cardiology and cardiac surgery) and
procedures, not primarily related to radiology, is permanently
growing. This role is mainly driven by the sophisticated
opportunities offered by medical computing and radiological
image guidance with regard to precision and minimal inva-
siveness [2]. However, the impact of radiology on the regula-
tory medico-legal, technical and radioprotection issues in this
field have not yet been defined. Since an increasing number of
procedures will probably be performed by non-radiologists,
several main questions have to be addressed:
& How should the radiology training requirements for non-
radiologists be provided?
& How should the technical and radioprotection related
responsibilities for radiological imaging systems used
by non-radiologists be organised?
& How should radiologists be involved in the practical
routine use of non-radiological image-guided proce-
dures in clinical practice?
Considering the almost pan-European medical reality with
decreasing staff resources and increasing diversification and
subspecialisation, radiologists have to stress the fact that with-
in a cooperative, goal-oriented and multidisciplinary environ-
ment, the specialty-specific knowledge should confer upon
radiologists a significant impact on the overall responsibility
for all imaging-related processes in various non-radiological
specialties (such as purchase, servicing, quality manage-
ment, radiation protection and documentation). Further-
more, radiologists should take responsibility for the
definition and compliance with the legal requirements
regarding all radiological imaging, especially if non-
radiologists have to be trained in the use of imaging technol-
ogy for guidance of therapy.
Classification of IGT and IGT Catalogue
IGT can be classified according to the type of procedure, the
target organ/type of tumour and the intended result. An impor-
tant fact is that a reasonable number of these procedures are
performed by non-radiologists. As long as radiation exposure is
a component of most image guidance (e.g. intraoperative fluo-
roscopy in hybrid operating theatres), national and international
radiation protection guidelines have to be fulfilled and the
referring, practicing, and operating part under Euratom legisla-
tion have to be qualified and certified.
Most IGT procedures relate to diagnostic and therapeutic
interventions such as evacuation/decompression, revascular-
isation/devascularisation, pain relief, critical life conditions
(e.g. acute bleeding) and tumour control (palliative, curative).
The catalogue of IGT procedures is impossible to sum-
marise and continuously enlarges. For clarification purpo-
ses, the following is a schematic approach:
& IGT in non-tumour conditions such as:
1. Transvascular and endovascular procedures
(a) Recanalisation, revascularisation by percutaneous
balloon angioplasty, stent placement, aortic grafts,
atherectomy, thrombectomy and thrombolysis.
(b) Devascularisation by placement of embolising ma-
terial as coils, particles and dedicated fluids.
(c) Others such as ablation of varices, renal artery radio-
frequency ablation (RFA), reperfusion by fibrinolysis,
intravascular drug-therapy, TIPS and transjugular bi-
opsy, IVC filter placement, valvuloplasty.
2. Non-vascular procedures
(a) General, including puncture, drainage and evacua-
tion. Placement of “assistance devices” such as
fiducials.
(b) Musculoskeletal: osteoplasty, kyphoplasty and
placement of stabilisation materials, intervertebral
disc treatment.
(c) Abdominal organs (mainly liver and kidney):
drainage, instillation therapies (e.g. in echinococ-
cal cysts) and endoscopic procedures (e.g. endolu-
minal stenting).
(d) Central nervous system: neuronavigation proce-
dures (e.g. deep brain stimulation).
& IGT in tumours
1. Trans-vascular procedures
(a) Embolisation (bland, drug eluting, non-permanent)
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(b) Chemo-ablative (including organ-selective perfu-
sion): chemo-perfusion and chemo-embolisation.
(c) Radio-ablative
2. Non-vascular procedures
(a) Thermally ablative, such as radiofrequency ablation,
microwave ablation, cryo-ablation and laser ablation.
(b) Thermo-mechanical ablative, as highly intensive
focused US.
(c) Electro-ablative, as irreversible electroporation.
(d) Chemo-ablative, such as ethanol (acetoacid)
injection.
3. IGT in supportive conditions
(a) Pain therapy by instillation (drugs, alcohol and
acetoacid, implant-like substances such as cement)
or thermal coagulation.
(b) Others, such as port-caths.
4. IGT in surgical procedures
(a) Intraoperative fluoroscopy, US, CT and MRI guid-
ed, monitored and controlled procedures by either
direct imaging of a target or probe placement.
(b) Intraoperative angiography under C-arm fluorosco-
py or DSA (plus flat panel CT-like techniques) and
related interventions.
5. IGT in radiation oncology
(a) Radiation treatment planning. Monitoring radiation
therapy by navigator techniques and motions
detection.
(b) Fluoroscopic, US, CT or MRI guided placement of
fiducials and radiation catheters (brachytherapy, after
loading).
Quality and medico-legal dependent characteristic of IGT
IGT involves a significant number of medical specialities. The
involved procedures should have agreed technical, methodo-
logical and legal prerequisites before being constituted within
an individual subspecialty. Defined prerequisites have to be
fulfilled for equipment and materials, but also for medical
environments to guarantee a safe and efficient practice.
Performing IGT necessitates specific quality manage-
ment tools for establishing standards and maintaining
levels of excellence. Therefore, radiologists should be
involved in identifying and establishing centres of ex-
cellence for training and support (e.g. “help desk”), and
establishing quality measures (e.g. definition of outcome
parameters for specific procedures). Quality and safety
standards have already been incorporated into IGT by
several national and international organisations, scientif-
ic and professional societies (such as the Society of
Interventional Radiology [SIR], Cardiovascular and
Interventional Radiological Society of Europe [CIRSE],
and European Society of Cardiology [ESC]).
A European task force group on IGT might be nec-
essary to further develop certification guidelines and
establish requirements for IGT practice according to
known standards, focused on common recommendations
and certification guidelines. The involved scientific and
professional societies should collaborate in the recom-
mendations on training programmes and accreditation of
IGT practices, crossover knowledge and collaborative
efforts. These documents will guide professionals in
complementing the quality certification with high safety
standards regarding clinical practice guidelines, appro-
priate equipment use, good operational techniques, prop-
er training, and adequate medical environment. The
proper definition of adequate targets and the use of
structural, functional and molecular biomarkers in these
procedures should be clearly defined and evaluated.
Moreover, within the European Organisation for Research
and Treatment of Cancer (EORTC), an EORTC imaging group
has already been created to ensure standardisation of image
acquisition and quality assurance of imaging investigations
(such as CT, PET-CT and MRI) used for EORTC trials. This
group involves several subgroups, including a Radiology Tech-
nologies Committee and an Imaging in Radiotherapy Commit-
tee that essentially deals with IGT. The European Society of
Radiology should lead in the production of a shared document
with all the involved societies and organisations in this matter.
Training programmes organised by ESIR (European
School of Interventional Radiology), certification by EBIR
(European Board of Interventional Radiology), as well as
numerous state-of-the-art documents on the performance
and also radiation protection in IGT presented by CIRSE,
are already well established and accepted initiatives, and
should be promoted even more.
All IGT procedures involving ionising radiation should
include the measurement and recording of appropriate tech-
nical equipment factors used in the procedure. These data
should be standardised, displayed and recorded. The Euro-
pean Union Directive on Medical Exposures [3] considers
the use of appropriate means of radiation protection and
insists that special attention should be given to quality
assurance programmes including quality control measures
and patient dose assessment.
The European Commission has funded several research
actions (such as DIMOND [4] and SENTINEL [5]) focused
on radiation protection aspects such as recording radiation
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dose information. Development of local programmes imple-
menting software-based models to collect and manage this
information should be promoted.
Radiation protection is of utmost importance for both
diagnostic and therapeutic procedures in IGT. The European
Directive 97/43/EURATOM on medical exposure, article 9
[3], addresses interventional techniques, as an example of a
procedure that can involve high doses of radiation to
patients and establishes certain requirements for its practice.
Most interventional radiology societies include radiation
protection aspects as part of their quality programmes [6].
With respect to radiation protection, the United Nations
Scientific Committee on the Effects of Atomic Radiation
(UNSCEAR) [7], the International Commission on Radiolog-
ical Protection (ICRP) [8] and the International Atomic Ener-
gy Agency (IAEA) have all contributed to improve radiation
safety aspects in recent years.
Strategies for increasing the “visibility” of IGT
Physicians within various medical specialties perform IGT.
In some areas within this field, radiologists and radiology
departments are not involved at all, while in others radiol-
ogists and other physicians have developed specific proce-
dures. IGT performed by radiologists is almost always free
from problems related to self-referral. From a medical point
of view, this independent position should be recognised and
brought to the attention of healthcare providers.
Promotion of training and education in IGT
As image-guided and minimally invasive therapy progresses
in complexity and volume with the development of new
technical and biological knowledge, it becomes obvious that
none of the existing medical specialities offer the ideal
clinical and technological training on this field. Clinical,
technical and biological fundaments are needed to adequate-
ly incorporate IGT procedures to the benefit of the patient.
In radiology, image guidance is the cornerstone of percu-
taneous and intravascular interventional procedures and
assists in a targeted minimally invasive treatment approach.
As a consequence, image guidance has to be an integral part
of the residency training, incorporated into the curriculum of
radiology and including all fluoroscopy, US, CT, and MR
guidance techniques. Postgraduate education in IGT is also
already provided by ESR and its subspecialty societies (such
as CIRSE, ESGAR, ESUR and EUSOBI), the European
School of Radiology (ESOR) and approved by a standar-
dised examination (European Board of Interventional Radi-
ology, EBIR). Nevertheless, to guarantee a comprehensive
service in IGT, the promotion of postgraduate education on
IGT has to be clearly extended.
For radiologists, a potential postgraduate education
programme should include the acquisition of a recognised
European board certification in interventional radiology,
such as provided by the ESR and CIRSE (EBIR), or even
a board certification in IGT. The European qualification is
aimed at standardising comprehensive training and expertise
in IGT and could be the first step in recognition of this sub-
speciality.
If non-radiological specialities are incorporating the use
of radiological techniques as IGT within their training cur-
riculum or are planning a postgraduate educational activity
involving imaging techniques, it seems mandatory to do this
in concordance with the existing national and international
requirements for education in radiation protection and pa-
tient safety, and in close cooperation with national radiolog-
ical societies to maintain quality standards. Radiologists
should be involved in these training programmes to guaran-
tee these standards.
Research issues and strategies
IGT research can be broadly divided into two categories,
target specific research (e.g. the type of tumour or vascular
lesion by imaging biomarkers) and technical research (e.g.
evaluation of a new device or procedure). Understanding the
efficacy and application of new and emerging technologies is
a critical first step, which then leads to target-specific research.
The focus of this research is aimed at understanding when,
where and in whom the therapy can provide clear clinical
benefit and how to use IGT in conjunction with, or as an
alternative to, more established therapies. This also clearly
includes research on the development and implementation of
imaging biomarkers, defined as objectively measured indica-
tors of normal biological processes, pathological changes, or
responses to a therapeutic intervention [9].
Current IGT research has been hampered by lack of the
type of funding provided by industry-led research such as is
available for pharmaceutical, novel radiotherapy or surgical
treatments. Construction of databases using pooled data from
multiple centres, some of them financed by industry, is worth-
less unless there are very strict controls on data quality and
organisation. Clinical specialists who lack the knowledge and
expertise required to champion IGTand who are often already
over-committed in pursuing their own research goals often
dominate committees in control of other funding streams.
IGT research should focus on proof of concept and out-
come using widely accepted clinical measures and imaging
biomarkers of response. Whilst the cost effectiveness of IGT
compared with conventional surgery (including follow-up
imaging and allowing for recurrence) is usually fairly obvi-
ous, precise records will be needed to convince healthcare
managers and government departments who are constantly
searching for cheaper and less invasive treatments. ESR and
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the European Institute for Biomedical Imaging Research
(EIBIR) can act as a catalyst for new research studies
by linking academic and researching centres, co-
ordinating protocols, facilitating data collection and
analysis.
Cooperation with other medical specialties/societies/clinical
partners
The therapeutic role of IGT makes it part of the treatment
algorithm in several diseases where this approach can be
used as a combined, sequential or stand-alone treatment. In
this regard, IGT providers must have extensive knowledge
of the disease and processes they treat with specific focus on
other therapeutic possibilities. Because IGT necessitates
awareness, concern, questioning and improvement about
therapeutic options for a given disease, a strong relationship
with other medical specialties and medical societies treating
the same type of disease by other means is mandatory, so
that treatment options for a patient are standardised. This
will allow improvement of knowledge by permanent dis-
cussion and exchange of information.
Moreover, validation of IGT obviously requires evaluation
of the treatment outcomes that will inevitably require head-to-
head comparison with other different medical/surgical/radia-
tion therapies, and also evaluation of complex therapeutic
strategies with the combination of IGT and other treatments.
These evaluations will have to be performed with medical
trials that can take place mainly through disease or organ-
oriented societies (e.g. ESMO, ESTRO, ECCO, EORTC). This
cooperation must involve IGT providers, other medical socie-
ties and medical specialist. Such collaboration by medical
societies must reflect what takes place in daily practice with
IGT providers investing time in multidisciplinary meetings to
enable further dissemination of their technique and understand-
ing of the disease treatment concepts.
Non-professional public awareness
The visibility and acknowledgements for IGT amongst other
medical specialties is still very low. The non-professional
public awareness is even lower. Activities to increase aware-
ness amongst non-professionals should aim for target
groups, such as politicians, healthcare providers, local hos-
pital administrators and patient’s organisations. All of these
target groups play an important role in improving recogni-
tion, financing and support for IGT.
Politicians are probably the most difficult to influence, as
they are usually not focused on a specific topic and have
little commitment which reaches beyond their term of office.
Lobby activities to probably get IGT on a political agenda
will only work in relation to a major disease group, like
diabetes and cancer, whereas the major issue of political
interest is mainly the escalating cost of healthcare that
necessitate comprehensive cost-effectiveness studies.
Healthcare providers, such as insurance companies, National
Health Services and local hospital administrations are a more
reliable and stable group with whom to enter discussion. How-
ever, they only have limited interests in cost-effectiveness,
quality, and safety data. Activities in this area might be sup-
ported by cooperation with institutions such as NICE (National
Institute of Clinical Excellence) in the UK.
As mentioned, patients play a very important role in
promoting and supporting IGT. Creating more awareness
among patients typically encompasses:
& Patient information provided by brochures and websites
with up-to-date information on IGT.
& Promoting IGT in the news media and popular press.
& Promotion of direct access of patients to IGT (establish-
ing contact via websites, IGT providers, hospital, na-
tional radiological societies).
Health economics and health technology assessment
IGT can contribute to medical care in two main ways, and
this will affect the calculations of cost effectiveness of the
procedure, that is the cost per unit of patient benefit.
& Replacing or improving existing more invasive or less
accurate techniques to deliver the same therapeutic
result.
& Delivering a novel treatment, not otherwise available.
For those who fund healthcare, the best use of resources
is achieved through promoting treatments that provide the
greatest patient benefit at the lowest cost, thereby purchas-
ing the maximum health gain for the population. This holds
true not only for state-funded healthcare and insurance-
based systems, but also for individually funded care. In
deciding which techniques are the most cost effective, it is
usually necessary to compare the health gain and the cost of
a newer technique or procedure with the best conventional
alternative approach if that method were not available. The
degree of additional benefit in terms of cure or longer
disease-free survival will be estimated from the available
literature, and the costs of the procedure and treatment of
any complications calculated.
IGT techniques often replace or modify a more invasive
or less accurate procedure. If one assumes equal efficacy,
then the best cost effective approach is the cheaper. Calcu-
lating cost is not always straightforward and should include
all costs, including allowance for the total staff time, drug
and equipment use, hospital bed usage, and the treatment of
procedure-related complications. There are relatively few
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examples of published cost effectiveness analyses for IGT,
many of these procedures being at least as effective as
traditional techniques, with lower overall costs. Demonstra-
tion of the cost effectiveness of IGT methods of treatment
and targeting with formal quantification of financial as well
as patient benefit would encourage their wider adoption.
In a broad perspective, health technology assessment
(HTA) might be the way for the systematic evaluation of
health-relevant IGT procedures and methods, the effective-
ness, safety and economic viability of a health intervention, as
well as its social, ethical, legal and organisational effects; and
for providing a basis for decisions in the health system.
Conclusion
IGT has gained a substantial importance in healthcare serv-
ices and should be considered a crucial component in the
vast majority of therapy regimens that encompass nearly all
medical fields. The major advantages of IGT are the pre-
ciseness and safety of the performed procedures based on
imaging the adequate target. Due to the highly demanding
technical requirements, specific training and skills, compli-
ance to legal requirements is necessary in performing IGT.
Radiology, Nuclear Medicine, Surgery and Radiation Oncol-
ogy are specialties that will benefit from this field. However, in
terms of patient care therapy—and this may be especially true
for IGT—imaging specialties will have to be deeply involved in
the definition of the standards in IGT because agreements on the
best procedures, parametric imaging results, measurements,
analysis and presentations are essential in this rapidly evolving
field. Radiologists should also take responsibility for the
definition and compliance with the legal requirements regarding
radiological imaging performed by non-radiologists.
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